Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 15801-15850 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04597580
Personalised Disease Monitoring in Metastatic Breast Cancer
N/A
Active, not recruiting
97 participants
Started: May 8, 2019 · Completed: Jan 31, 2030
2 conditions
2 sponsors
7 locations
NCT03891953
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
PHASE1
Active, not recruiting
98 participants
Started: May 7, 2019 · Completed: Dec 31, 2025
5 conditions
1 sponsor
9 locations
NCT03929913
NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study
NA
Active, not recruiting
19 participants
Started: May 7, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT03729804
Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
PHASE3
Active, not recruiting
250 participants
Started: May 7, 2019 · Completed: Dec 28, 2026
1 condition
1 sponsor
1 location
NCT03570892
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
PHASE3
Active, not recruiting
331 participants
Started: May 7, 2019 · Completed: Feb 11, 2026
1 condition
1 sponsor
72 locations
NCT03905707
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
PHASE3
Active, not recruiting
145 participants
Started: May 7, 2019 · Completed: Oct 31, 2026
1 condition
1 sponsor
27 locations
NCT03757689
Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma
PHASE2
Active, not recruiting
63 participants
Started: May 6, 2019 · Completed: Feb 28, 2027
1 condition
1 sponsor
3 locations
NCT04017793
Mindfulness-Associated Brain Changes in Adults With Autism
NA
Active, not recruiting
108 participants
Started: May 6, 2019 · Completed: Dec 31, 2024
1 condition
3 sponsors
1 location
NCT03952078
A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma
PHASE1
Active, not recruiting
151 participants
Started: May 3, 2019 · Completed: Apr 30, 2026
1 condition
1 sponsor
22 locations
NCT03734809
NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer
PHASE2
Active, not recruiting
46 participants
Started: May 3, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
2 locations
NCT03781323
Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer
PHASE2
Active, not recruiting
12 participants
Started: May 3, 2019 · Completed: Jun 1, 2027
1 condition
1 sponsor
2 locations
NCT03919929
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
PHASE2/PHASE3
Active, not recruiting
60 participants
Started: May 3, 2019 · Completed: Jul 31, 2024
3 conditions
2 sponsors
1 location
NCT03845283
Creating an Optimized Technology-Based Weight Loss Program for Cardiac Rehabilitation Patients
NA
Active, not recruiting
198 participants
Started: May 2, 2019 · Completed: Sep 1, 2024
2 conditions
2 sponsors
1 location
NCT03599960
Combination Chemotherapy in Patients With Newly Diagnosed BPDCN
PHASE2
Active, not recruiting
26 participants
Started: May 2, 2019 · Completed: Nov 30, 2024
1 condition
6 sponsors
2 locations
NCT03371225
Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System
NA
Active, not recruiting
116 participants
Started: May 1, 2019 · Completed: Sep 25, 2025
1 condition
1 sponsor
1 location
NCT03916874
The Pregnancy & Early Life Study
N/A
Active, not recruiting
261 participants
Started: May 1, 2019 · Completed: Dec 1, 2025
1 condition
3 sponsors
1 location
NCT03775044
Assessment of Medherent Medication Management Device and Adherence Platform
NA
Active, not recruiting
150 participants
Started: May 1, 2019 · Completed: Mar 31, 2023
2 conditions
2 sponsors
1 location
NCT03348631
Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer
PHASE2
Active, not recruiting
62 participants
Started: May 1, 2019 · Completed: Feb 12, 2026
5 conditions
2 sponsors
586 locations
NCT03528642
Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
PHASE1
Active, not recruiting
40 participants
Started: May 1, 2019 · Completed: May 8, 2026
2 conditions
1 sponsor
25 locations
NCT03905148
Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors
PHASE1
Active, not recruiting
93 participants
Started: May 1, 2019 · Completed: Feb 28, 2026
1 condition
2 sponsors
6 locations
NCT03808103
Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: May 1, 2019 · Completed: Jun 1, 2026
1 condition
3 sponsors
2 locations
NCT03710772
Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
PHASE2
Active, not recruiting
51 participants
Started: May 1, 2019 · Completed: Mar 22, 2027
1 condition
2 sponsors
1 location
NCT02653287
Lupus Intervention for Fatigue Trial
NA
Active, not recruiting
200 participants
Started: May 1, 2019 · Completed: Dec 31, 2025
3 conditions
1 sponsor
2 locations
NCT03843528
Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation
PHASE1
Active, not recruiting
15 participants
Started: May 1, 2019 · Completed: Oct 30, 2026
4 conditions
1 sponsor
1 location
NCT03941236
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism
PHASE3
Active, not recruiting
44 participants
Started: May 1, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
10 locations
NCT03838016
Preventing Speech and Language Disorders in Children With Classic Galactosemia
EARLY_PHASE1
Active, not recruiting
285 participants
Started: May 1, 2019 · Completed: Aug 31, 2025
3 conditions
2 sponsors
1 location
NCT03939026
Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma
PHASE1
Active, not recruiting
74 participants
Started: May 1, 2019 · Completed: Aug 31, 2026
2 conditions
1 sponsor
7 locations
NCT03899402
Triple Therapy in T1DM
PHASE2/PHASE3
Active, not recruiting
78 participants
Started: May 1, 2019 · Completed: Mar 31, 2026
1 condition
3 sponsors
1 location
NCT05527782
Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
PHASE2
Active, not recruiting
40 participants
Started: May 1, 2019 · Completed: Oct 31, 2025
1 condition
1 sponsor
3 locations
NCT04616144
Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism
NA
Active, not recruiting
55 participants
Started: May 1, 2019 · Completed: May 1, 2026
2 conditions
1 sponsor
1 location
NCT03813394
Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC
PHASE1/PHASE2
Active, not recruiting
48 participants
Started: May 1, 2019 · Completed: Jun 1, 2025
2 conditions
2 sponsors
1 location
NCT04307602
Long-term Exercise Effects from Robotic Walking
NA
Active, not recruiting
60 participants
Started: May 1, 2019 · Completed: Dec 31, 2026
3 conditions
4 sponsors
1 location
NCT04781205
Genome Driven Primary Care Clinics - an RCT
NA
Active, not recruiting
200,000 participants
Started: May 1, 2019 · Completed: Dec 31, 2029
3 conditions
1 sponsor
1 location
NCT03764553
Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer
PHASE2
Active, not recruiting
320 participants
Started: May 1, 2019 · Completed: Jul 1, 2026
1 condition
2 sponsors
34 locations
NCT03860987
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer
PHASE2
Active, not recruiting
12 participants
Started: Apr 30, 2019 · Completed: Aug 1, 2028
1 condition
1 sponsor
1 location
NCT03907527
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE1
Active, not recruiting
71 participants
Started: Apr 30, 2019 · Completed: Nov 15, 2028
34 conditions
1 sponsor
2 locations
NCT03944603
Longitudinal Innate Immunity and Aging Study
N/A
Active, not recruiting
300 participants
Started: Apr 30, 2019 · Completed: Mar 31, 2025
1 condition
2 sponsors
1 location
NCT03478462
Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
PHASE1
Active, not recruiting
30 participants
Started: Apr 30, 2019 · Completed: Dec 31, 2026
8 conditions
1 sponsor
8 locations
NCT03748550
Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)
NA
Active, not recruiting
7 participants
Started: Apr 29, 2019 · Completed: Dec 31, 2025
3 conditions
3 sponsors
2 locations
NCT03985189
Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
PHASE1
Active, not recruiting
14 participants
Started: Apr 29, 2019 · Completed: May 31, 2028
1 condition
1 sponsor
9 locations
NCT03847428
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment
PHASE3
Active, not recruiting
908 participants
Started: Apr 29, 2019 · Completed: May 31, 2027
1 condition
1 sponsor
217 locations
NCT03586661
Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PHASE1
Active, not recruiting
31 participants
Started: Apr 29, 2019 · Completed: Dec 31, 2026
11 conditions
2 sponsors
1 location
NCT03937726
Boiled Peanut Immunotherapy for the Treatment of Peanut Allergy
NA
Active, not recruiting
83 participants
Started: Apr 29, 2019 · Completed: May 31, 2027
2 conditions
2 sponsors
1 location
NCT03838549
Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic Indication
NA
Active, not recruiting
20 participants
Started: Apr 26, 2019 · Completed: May 31, 2025
2 conditions
2 sponsors
1 location
NCT03872947
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
138 participants
Started: Apr 26, 2019 · Completed: Jun 30, 2026
12 conditions
1 sponsor
14 locations
NCT03666741
Inspiris Resilia Durability Registry
N/A
Active, not recruiting
400 participants
Started: Apr 26, 2019 · Completed: Jul 31, 2026
1 condition
2 sponsors
21 locations
NCT03901963
A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant
PHASE3
Active, not recruiting
200 participants
Started: Apr 26, 2019 · Completed: May 29, 2026
1 condition
1 sponsor
73 locations
NCT03156790
PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia
PHASE2
Active, not recruiting
40 participants
Started: Apr 26, 2019 · Completed: May 31, 2026
1 condition
2 sponsors
8 locations
NCT04997005
The Medacta International AMIStem-P Post-Marketing Surveillance Study
N/A
Active, not recruiting
550 participants
Started: Apr 26, 2019 · Completed: Dec 31, 2032
5 conditions
1 sponsor
5 locations
NCT03951337
64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)
PHASE2
Active, not recruiting
70 participants
Started: Apr 26, 2019 · Completed: Jan 31, 2026
1 condition
2 sponsors
5 locations
Previous
1
More pages
314
315
316
317
318
319
320
More pages
431
Next